[HTML][HTML] Recurrence of hepatocellular carcinoma after liver transplantation: risk factors and predictive models

WA Straś, D Wasiak, B Łągiewska… - Annals of …, 2022 - ncbi.nlm.nih.gov
Liver transplantation (LTx) is the best treatment for patients with early-stage hepatocellular
carcinoma (HCC). The Milan criteria positively influenced results of liver transplantation and …

Hedgehog signaling, a critical pathway governing the development and progression of hepatocellular carcinoma

J Ding, HY Li, L Zhang, Y Zhou, J Wu - Cells, 2021 - mdpi.com
Hedgehog (Hh) signaling is a classic morphogen in controlling embryonic development and
tissue repairing. Aberrant activation of Hh signaling has been well documented in liver …

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation

WF Qu, MX Tian, HW Lu, YF Zhou, WR Liu… - Hepatology …, 2023 - Springer
Background and purpose Tumor recurrence after liver transplantation (LT) impedes the
curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a …

An injectable hydrogel with pH-sensitive and self-healing properties based on 4armPEGDA and N-carboxyethyl chitosan for local treatment of hepatocellular …

J Zhan, Y Wu, H Wang, J Liu, Q Ma, K Xiao, Z Li… - International Journal of …, 2020 - Elsevier
Injectable hydrogels with pH-sensitive and self-healing properties have great application
potential in the field of anti-cancer drug carriers. In this work, an injectable hydrogel is …

Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

PX Wang, Y Xu, YF Sun, JW Cheng, KQ Zhou… - Liver …, 2021 - Wiley Online Library
Abstract Background & Aims Liver transplantation (LTx) is one of the most effective
treatments for hepatocellular carcinoma (HCC); however, tumour recurrence after LTx often …

[HTML][HTML] Venous thromboembolism in inflammatory bowel disease

K Cheng, AS Faye - World journal of gastroenterology, 2020 - ncbi.nlm.nih.gov
Patients with inflammatory bowel disease (IBD) are at an increased risk for venous
thromboembolism (VTE). VTE events carry significant morbidity and mortality, and have …

The management of post-transplantation recurrence of hepatocellular carcinoma

L Rajendran, T Ivanics, MPAW Claasen… - Clinical and …, 2021 - pmc.ncbi.nlm.nih.gov
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two
decades, liver transplantation (LT) has become the preferable treatment of HCC, when …

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma

RS Rios, KI Zheng, MH Zheng - Chinese medical journal, 2021 - journals.lww.com
The emergence of non-alcoholic fatty liver disease (NAFLD) as the leading chronic liver
disease worldwide raises some concerns. In particular, NAFLD is closely tied to sedentary …

Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma …

BV Tran, D Moris, D Markovic, H Zaribafzadeh… - Liver …, 2023 - journals.lww.com
HCC recurrence following liver transplantation (LT) is highly morbid and occurs despite strict
patient selection criteria. Individualized prediction of post-LT HCC recurrence risk remains …

The importance of AFP in liver transplantation for HCC

F Özdemir, A Baskiran - Journal of gastrointestinal cancer, 2020 - Springer
Introduction The most common biomarker for HCC is serum alpha-fetoprotein (AFP). AFP is
used for screening and diagnosing HCC, and also, it is used for predicting prognosis and …